Related Experiment Video

Updated: Jan 8, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.7K

CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies

Mingyao Huang1,2, Siyang Wang3, Huiyan Huang4

  • 1School of Basic Medicine, Putian University, Putian, Fujian, China.

Frontiers in Immunology
|December 22, 2025
PubMed

Insights

Chimeric antigen receptor (CAR)-engineered natural killer (NK) cells offer a promising new immunotherapy for gynecological cancers. Research explores their development, application, and strategies to overcome challenges for improved patient outcomes.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cellular Therapy

Background:

  • Gynecological malignancies pose a significant global health challenge.
  • Current treatments face limitations due to late detection and treatment resistance.

Purpose of the Study:

  • To review the development and application of CAR-NK cells in gynecological cancers.
  • To examine challenges and propose strategies for enhancing CAR-NK therapy effectiveness and safety.

Main Methods:

  • Exploration of CAR-NK cell sources and design.
  • Analysis of current obstacles in CAR-NK therapy.
  • Discussion of innovative strategies for CAR-NK cell optimization.

Main Results:

  • CAR-NK cells represent a novel immunotherapy approach for gynecological cancers.
  • Identification of key challenges and potential solutions for CAR-NK therapy.

Conclusions:

  • CAR-NK cell therapy holds significant potential for treating gynecological cancers.
  • Ongoing research and innovation are crucial for realizing the full therapeutic benefits of CAR-NK cells.
Keywords:
CAR-NK cellsgynecological cancersimmunomodulationimmunotherapytumor immune microenvironment

More Related Videos

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

6.3K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

709

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.8K